Posted on 22/02/2010 in Medical Company Product News Covidien has signed an agreement with the Institute of Atomic Energy in Poland (IAE Polatom) over the provision of a new source of medical isotopes.
Under the terms of the agreement, IAE Polatom's Maria Research Reactor is to become part of the medical device company's global supply chain of Technetium 99m.
The isotope is regarded as a vital component in nuclear medicine diagnostic and functional studies and is used by radiologists, nephrologists and oncologists to study organs and anatomical systems.
Timothy Wright, president of pharmaceuticals at Covidien, described the deal as an "historic agreement", as it is the first time in several decades that a new reactor has become part of the global medical isotope supply chain.
He added: "We are excited that we will now be working together to provide more than a million patients around the globe with access to a critical medical isotope during this serious shortage."
Last month, the company published its financial breakdown for the first quarter of the fiscal year, during which its sales grew by seven per cent year-on-year.Other news stories from 22/02/2010
Read more in the Zenopa News Archive
How this news is generated
|
